Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program

Cancer Chemother Rep. 1968 Oct;52(6):655-60.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Breast Neoplasms / drug therapy
  • Clinical Trials as Topic
  • Gastrointestinal Neoplasms / drug therapy
  • Humans
  • Lung Neoplasms / drug therapy
  • Lymphoma / drug therapy*
  • Melanoma / drug therapy
  • Mercaptopurine / adverse effects*
  • Mercaptopurine / therapeutic use*
  • Mercaptopurine / toxicity*
  • Neoplasms / drug therapy*

Substances

  • Mercaptopurine